AAM
Arabesque Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-22,653
| Closed | -$1.69M | – | 53 |
|
|
2022
Q4 | $1.69M | Hold |
22,653
| – | – | 0.57% | 85 |
|
|
2022
Q3 | $1.87M | Sell |
22,653
-13,855
| -38% | -$1.14M | 0.91% | 71 |
|
|
2022
Q2 | $3.47M | Sell |
36,508
-1,380
| -4% | -$131K | 1.83% | 3 |
|
|
2022
Q1 | $4.46M | Sell |
37,888
-991
| -3% | -$117K | 1.55% | 7 |
|
|
2021
Q4 | $5.04M | Buy |
38,879
+18,904
| +95% | +$2.45M | 1.45% | 6 |
|
|
2021
Q3 | $2.26M | Buy |
19,975
+17,156
| +609% | +$1.94M | 0.76% | 47 |
|
|
2021
Q2 | $292K | Sell |
2,819
-13,767
| -83% | -$1.43M | 0.12% | 120 |
|
|
2021
Q1 | $1.39M | Buy |
16,586
+1,586
| +11% | +$133K | 0.61% | 51 |
|
|
2020
Q4 | $1.37M | Sell |
15,000
-7,919
| -35% | -$722K | 0.41% | 43 |
|
|
2020
Q3 | $1.83M | Buy |
+22,919
| New | +$1.83M | 1.64% | 35 |
|
|
2020
Q1 | – | Sell |
-16,711
| Closed | -$3.9M | – | 71 |
|
|
2019
Q4 | $3.9M | Buy |
16,711
+1,937
| +13% | +$452K | 1.5% | 13 |
|
|
2019
Q3 | $3.25M | Buy |
14,774
+6,674
| +82% | +$1.47M | 1.5% | 25 |
|
|
2019
Q2 | $1.5M | Buy |
+8,100
| New | +$1.5M | 0.68% | 68 |
|